Abstract
Streptonigrin (Fig. 1), a metabolite produced by Streptomyces flocculus, was first isolated by Rao and Cullen (1959–60). Its activity as a broad spectrum antibiotic was summarized in a previous review (Bhuyan, 1967). A method for the biological assay of streptonigrin in biological fluids based on its antibiotic activity against Bacillus subtilis ATCC6633 has been developed by Pittillo and Woolley (1974). Exposure to streptonigrin caused a first-order decline in the viability of bacteria, implying that only one hit per cell is required for lethality (Levine and Borthwick, 1963 a). Streptonigrin is also an excellent inducer of bacteriophage production in lysogenic bacteria while inhibiting the net synthesis of host DNA (Levine and Borthwick, 1963 a; Muschel and Schmoker, 1966). A marked increase in genetic recombination was observed during a mixed bacteriophage infection in presence of the drug (Levine and Borthwick, 1963 b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antipov, I.G., Navitsky, V.V., Goldberg, E.D.: Myeloinhibitory effect of some antitumor antibiotics and its comparative estimation. Antibiotiki 20, 897–902 (1975)
Baumanis, E.A., Elksnite, J.E., Liepinia, V.A.: Effect of antibiotic preparation on the enzymes of serotonin metabolism in the liver of mice. Vopr. Onkol. 19, 36–39 (1973)
Bhuyan, B.K.: Phleomycin, xanthomycin, streptonigrin, nogalomycin and aurantin. In: Antibiotics, mechanism of action. Gottlieb, D., Shaw, P.D. (eds.), Vol. I, pp. 175–176. Berlin, Heidelberg, New York: Springer 1967
Brazhnikova, M.G., Ponomarenko, V.I., Kovsharova, I.N., Kruglyak, E.B., Proshlyakova, V.V.: Study of bruneomycin produced by Act. Albus var. bruneomycini, and its identification with streptonigrin. Antibiotiki 13, 99–102 (1968)
Chaube, S., Kuffer, F.R., Murphy, M.L.: Comparative teratogenic effects of streptonigrin (NSC-45383) and its derivates in the rat. Cancer Chemother. Rep. 53, 23–31 (1969)
Chirigos, M.A., Luber, E., March, R., Pettigrew, H.: Antiviral chemotherapeutic assay with Friend leukemia virus in mice. Cancer Chemother. Rep. 45, 29–33 (1965)
Chirigos, M.A., Pearson, J.W., Papas, T.S., Woods, H.B., Jr., Spahn, G.: Effect of streptonigrin (NSC-45383) and analogs on oncorna replication and DNA polymerase. Cancer Chemother. Rep. 57, 305–309 (1973a)
Chirigos, M.A., Pearson, J., Spahn, G., Rutman, R.: Current studies on oncorna virus therapy. Bibl. Haematol. 39, 1208–1219 (1973b)
Chiu, Y.Y., Lipscomb, W.N.: Molecular and crystal structure of streptonigrin. J. Am. Chem. Soc. 97, 2525–2530 (1975)
Cohen, M.M.: Thee specific effects of streptonigrin activity on human chromosomes in culture. Cytogenetics 2, 271–279 (1963)
Cohen, M.M.L: The interaction of various drugs with human chromosomes. Can. J. Genet. Cytol. 11, 1–24 (1969)
Cohen, M.M., Shaw, M.W., Craig, A.P.: The effects of streptonigrin on cultured human leukocytes. Proc. Natl. Acad. Sci. USA 50, 16–24 (1963)
Cone, R., Hasan, S.K., Lowan, J.W., Morgan, A.R.: The mechanism of the degradation of DNA by streptonigrin. Can. J. Biochem. 54, 219–223 (1976)
Driscoll, J.S., Hazard, G.F., Jr., Wood, H.B., Jr., Goldin, A.: Structure-antitumor activity relationships among quinone derivatives. Cancer Chemother. Rep. 4, (Pt 2, No 2), 1–362 (1974)
Dudnik. J.V.: Induction of lysogenic Micrococcus lysodiekticus by antibiotics with the ability to affect DNA synthesis. Antibiotiki 2, 112–117 (1965)
Dudnik, J.V., Gause, G.G.: Mechanism of bruneomycin action. Fed. Proc. 25, 1109–1112 (1966)
Dudnik, J.V., Netyksa, E.M., Varik, O.Y.: Increased antibacterial effect of bruneomycin and sibiromycin in cultures with impaired reparation of DNA. Antibiotiki 16, 487–491 (1971)
Dudnik, J.V., Gause, G.G., Karpov, V.L., Kozmyan, L.I., Padron, F.: On interaction in vitro of bruneomycin (streptomycin) with DNA. Antibiotiki 18, 968–973 (1973)
Ebert, P.S., Chirigos, M.A., Ellsworth, P.A.: Differential response of Friend leukemia virus and lactate dehydrogenase virus to chemotherapy and in vitro neutralization. Cancer Res. 28, 363–367 (1968)
Ebringer, L.: Are plastids derived from prokaryotic microorganisms? Action of antibiotics on chloroplasts of Euglena gracilus. J. Gen. Microbiol. 71, 35–52 (1972)
Furusawa, E., Furusawa, S., Lee, J.V.B., Petanavanich, S.: Therapeutic activity of pretazettine, a narcissus alkaloid on Rauscher leukemia ; comparison with tazettine and streptonigrin. Proc. Soc. Exp. Biol. Med. 152, 186–191 (1976)
Gause, G.G., Jr., Mikhailov, V.S.: State of DNA synthesizing system in isolated mitochondria from the mature egg of the loach (Misgurnus fossilis). Biochem. Biophys. Acta 324, 189–198 (1973)
Giraldi, A., Carco, F.P., Giraldi, M., Novati, M.: Antimitotic activity of streptonigrin. G. Ital. Chemioter. 14, 13–19 (1967)
Goldberg, E.D., Salnik, G. A.: Bruneomycin effect on energy metabolism of liver tissue in experiment. Antibiotiki 20, 66–71 (1975)
Gregory, E.M., Fridovich, I.: Oxygen toxicity and the Superoxide dismutase. J. Bacteriol. 114, 1193–1197(1973)
Hassan, H.M., Fridovich, I.: Enzymatic defenses against the toxicity of oxygen and of streptonigrin in E. coli J. Bacteriol. 129, 1574–1583 (1977)
Hays, E.F.: Metabolic inhibitors and viral lymphomagenesis in thymic grafts. J. Natl. Cancer Inst. 53, 561–566 (1974)
Hochstein, P., Laszlo, J., Miller, D.: A unique, dicumarol-sensitive, non-phosphorylating oxidation of DPNH and TPNH catalyzed by streptonigrin. Biochem. Biophys. Res. Commun. 19,289–295 (1965)
Ishizu, K., Dearman, H.H., Huang, M.T., White, J.R.: Electron paramagnetic resonance observation on biogenic semiquinone and 5-methyl phenylphenazinum radicals. Biochem. Biophys. Acta 165, 283–285 (1968)
Iyer, V.N., Szybalski, W.: Mitomycins and porfiromycin: chemical mechanism of activation and cross-linkeng of DNA. Science 145, 55–58 (1964)
Jagiello, G.: Streptonigrin effect on the first meiotic metaphase of the mouse egg. Science 157, 453–454 (1967)
Kihlman, B.A.: The production of chromosomal aberrations by streptonigrin in Vicia faba. Mutat. Res. 1, 54–62 (1964)
Kihlman, B.A., Odmark, G.: Deoxyribonucleic acid synthesis and the production of chromosomal aberrations by streptonigrin, 8-ethoxycaffeine and 1,3,7,9-tetramethyluric acid. Mutat. Res. 2, 494–505 (1965)
Kremer, W.B., Laszlo, J.: Biochemical effects of the methyl ester of streptonigrin. Biochem. Pharmacol. 15, 1111–1118(1966)
Kremer, W.B., Laszlo, J.: Comparison of biochemical effects of isopropylidine azastreptonigrin (NSC-62709) with streptonigrin (NSC-45383). Cancer Chemother. Rep. 52, 19–24 (1967)
Levine, M., Borthwick, M.: The action of streptonigrin on bacterial DNA metabolism and on induction of phage production in lysogenic bacteria. Virology 21, 568–574 (1963a)
Levine, M., Borthwick, M.: The action of streptonigrin on genetic recombination between bacteriophages. Proc. 11th Int. Congr. Genet., Netherlands: The Hague 1963b
Lown, J.W., Sim, S.K.: Studies related to antitumor antibiotics. Part VIII Cleavage of DNA by streptonigrin analogues and the relationship to antineoplastic activity. Can. J. Biochem. 54, 446–52 (1976)
Mcbride, T.J., Oleson, J.J., Woolf, D.: The activity of streptonigrin against the Rauscher murine leukemia virus in vivo. Cancer Res. 26, 727–732 (1966)
Mikhailov, V.S., Gause, G.G.: The DNA-synthesizing system of isolated mitochondria of unfertilized loach eggs and its artificial activation in vitro by the antibiotic bruneomycin. Mol. Biol. 8, 108–118 (1974)
Mikhailov, V.S., Gause, G.G.: Repair of damage caused by bruneomycin to DNA in isolated mitochondria of mature loach oocytes. Dokl. Akad. Nauk. SSSR 229, 1477–1480 (1976)
Miller, D.S., Laszlo, J., McCarty, K.S., Guild, W.R., Hochstein, P.: Mechanism of action of streptonigrin in leukemic cells. Cancer Res. 27, 632–638 (1967)
Mizuno, N.S.: Effects of streptonigrin on nucleic acid metabolism of tissue culture cells. Biochim. Biophys. Acta 108, 394–395 (1965)
Mizuno, N.S.: Distribution of tritiated methyl ester of streptonigrin in mice bearing sarcoma 180. Biochem. Pharmacol. 15, 394–403 (1966)
Mizuno, N.S.: Comparative effects of streptonigrin derivatives on tissue culture cells. Biochem. Pharmacol. 16, 933–940 (1967)
Mizuno, N.S., Gilboe, D.P.: Binding of streptonigrin to DNA. Biochim. Biophys. Acta 224, 319–327 (1970)
Mizuno, N.S., Humphrey, E.W.: Metabolism of tritiated methyl ester of streptonigrin (NSC-45384) in humans with cancer. Cancer Chemother. Rep. 41, 23–26 (1964)
Morgan, A.R., Cone, R.L., Elgert, T.M.: The mechanism of DNA strand breakage by vitamin C and Superoxide and the protective roles of catalase and Superoxide. Nucleic Acid Res. 3, 1139–1149(1976)
Muschel, L.H., Schmoker, K.: Activity of mitomycin C, other antibiotics, and serum against lysogenic bacteria. J. Bacteriol. 92, 967–971 (1966)
Nasjleti, C.E., Spencer, H.H.: Chromosome polyploidization in human leukocyte culture treated with streptonigrin and cyclophosphamide. Cancer 20, 31–35 (1967)
Oberdisse, E., Neubert, D.: Influence of several antibiotics, which can form complexes with DNA, on nucleic acid synthesis of warm-blooded animal cells in vivo. Nauyn-Schmiedebergs’ Arch. Pharmakol. Exp. Pathol. 257, 47–48 (1967)
O’Connor, T.E., Schoop-Stansly, P., Sethi, V.S., Hadidi, A., Okano, P.: Antibiotic control of infection of human or mouse cells with oncorna virus. Collect. Pap. Annu. Symp. Fundam. Cancer Res. 27, 319 (1975)
Oleson, J.J., Calderella, L.A., Mjos, K.J., Peith, A.R., Thie, R.S., Toplin, I.: The effects of streptonigrin on experimental tumors. Antibiot. Chemother. 11, 158–164 (1961)
Padron, E., Karpov, V.L., Gause, G.G., Dudnik, J.V.: Distribution of H3-bruneomycin in tumor cell. Antibiotiki 19, 387–389 (1974)
Pittillo, R.F., Woolley, C.: Biological assay of streptonigrin (NSC-45383) in body fluids and tissues of mice. Antimicrob. Agents Chemother. 5, 82–85 (1974)
Price, P.J., Suk, Wa.A., Spah, G.J., Chirigos, M.A., Lane, J.A., Huebner, R.J.: Streptonigrin inhibition of 3-methylcholanthrene transformation in vitro. Proc. Soc. Exp. Biol. Med. 145, 1197–1200(1974)
Puck, T.T.: Phasing, mitotic delay and chromosomal aberration in mammalian cells. Science 144, 565–566 (1964)
Pulich, W.M., Jr.: Resistance to high oxygen tension, streptonigrin and ultraviolet irradiation in the green alga Chlorella Sorokiniana strain ors. J. Cell Biol. 62, 904–907 (1974)
Radding, C. M.: Incorporation of 3H-thymidine by K12 (λ) induced by streptonigrin. In: Genetics today. Geerts, S.J. (ed.) p.22. Oxford: Pergamon Press 1963
Rao, K.V.: Quinone natural products; streptonigrin (NSC-45383) and lapachol (NSC-11905) structure-activity relationship. Cancer Chemother. Rep. 4 (Pt. 2, No 4), 11–17 (1974)
Rao, K.V., Cullen, W.P.: Streptonigrin, an antitumor substance, I. Isolation and characterization. Antibiot. Ann., 950–953 (1959–60)
Rao, K.V., Biemann, K., Woodward, R.B.: The structure of streptonigrin. J. Am. Chem. Soc. 85, 2532–2533 (1963)
Reilly, H.C., Sigiura, K.: An antitumor spectrum of streptonigrin. Antibiot. Chemother. 11, 174–177 (1961)
Shorin, V.A., Brazhanov, V.S.: Possibility of utilizing leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics. Antibiotiki 19, 679–684 (1974)
Soukup, S., Takacs, E., Warkany, S.: Chromosome changes in embryos treated with various teratogens. J. Embryol. Exp. Morphol. 18, 215–226 (1967)
Szybalski, W.: Structural modifications of DNA; crosslinking, circularization and single-strand interruptions. Abh. Dtsch. Akad. Berlin 4, 1–19 (1964)
Teller, M.N., Wagshul, S. F., Woolley, G. S.: Transplantable human tumors in experimental chemotherapy: effects of streptonigrin on HS #1 and HEP3 in the rat. Antibiot. Chemother. 11, 165–173 (1961)
Warkany, J., Takacs, E.: Changes of endocrine glands produced by teratogenic methods. The pituitary gland. Arch. Pathol. 85, 101–113 (1968)
White, H.L., White, J.R.: Interaction of streptonigrin with DNA in vitro. Biochim. Biophys. Acta 123, 648–651 (1966)
White, H.L., White, J.R.: Lethal action and metabolic effects of streptonigrin in E. coli. Mol. Pharmacol. 4, 549–565 (1968)
White, J.R., Dearman, H.H.: Generation of free radicals from phenazine methosulfate, streptonigrin, and rubiflavin in bacterial suspensions. Proc. Natl. Acad. Sci. USA 54, 887–891 (1965)
Woods, W.A., Massicot, J.G., Webb, J.H., Chirigos, M.A.: Inhibitory effect of streptonigrin on a murine sarcoma virus-induced tumor cell line (MSC) and selection of drug resistant clones. In Vitro 9, 24–30 (1973)
Young, C.W., Hodas, S.: Acute effects of cytotoxic compounds on incorporation of precursors into DNA, RNA and protein of HeLa monolayers. Biochem. Pharmacol. 14, 205–214 (1965)
Zee-Cheng, K.Y., Cheng, C.C.: Common receptor complement feature among some antileukemic compounds. J. Pharm. Sci. 59, 1630–1634 (1970)
Zetterberg, G., Kihlman, B.A.: Production of mutation by streptonigrin in the ascomycete Ophiostoma multiannulatum. Mutat. Res. 2, 470–71 (1965)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Mizuno, N.S. (1979). Streptonigrin. In: Hahn, F.E. (eds) Mechanism of Action of Antieukaryotic and Antiviral Compounds. Antibiotics, vol 5 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46407-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-46407-2_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46409-6
Online ISBN: 978-3-642-46407-2
eBook Packages: Springer Book Archive